RiskView Testing
Evidence-based testing to reduce therapeutic uncertainty
Introduction
Comprehensive Medication Insight
RiskView360 is an advanced urine-based test that offers a complete view of a patient’s medication profile, including prescribed drugs, over-the-counter substances, and their metabolites. By analyzing over 130 analytes, it identifies whether prescribed medications are present and flags any non-prescribed substances. This helps healthcare providers assess adherence, monitor safety, and make informed adjustments to a patient’s regimen—ensuring medications are both effective and appropriately followed.
Why the Test Is Significant
Flags Non-Compliance Issues
Identifies if patients are following their prescribed regimens
Prevents Adverse Drug Events
Reveals unexpected substances in the system
Monitors Metabolic Patterns
Tracks how substances are processed through ongoing testing
Evaluates Renal Drug Processing
Confirms if kidney-excreted drugs are functioning as expected
Unknown and Interesting Facts
RiskView360 features one of the most comprehensive urine-based panels available, detecting over 130 analytes with continual updates. Results are summarized into intuitive categories—“Prescribed Detected,” “Prescribed Not Detected,” and “Not Prescribed Detected”—for easy interpretation. Repeated testing reveals metabolic patterns and adherence trends over time. While Medicare may cover up to 12 tests annually, quarterly testing is generally sufficient for chronic care monitoring and medication reconciliation in complex patients.
Medical Necessity and Signs/Symptoms
- Patients with multiple chronic conditions
- Routine assessments during chronic care management visits
- Annual Wellness Visits and new patient intakes
- Transitional Care Management (post-hospital follow-up)
- Known or suspected non-compliance with prescribed medications
- Polypharmacy requiring ongoing risk assessment
- Medication reconciliation in elderly or complex patients
- Preventive care to avoid adverse drug events
Post-Test Support
Elite Clinical Laboratory provides concise, category-based reporting that makes it easy for clinicians to evaluate medication adherence and detect inconsistencies. Each report begins with a summary, followed by detailed analyte data and trending insights from historical results. Our team is available to support clinical interpretation and operational needs, including billing guidance and direct contact through Newstar representatives and a dedicated helpline—ensuring seamless integration into care workflows.